Rewalk Robotics (NASDAQ:RWLK) Stock Price Up 7%

Shares of Rewalk Robotics Ltd (NASDAQ:RWLK) were up 7% on Wednesday . The company traded as high as $2.18 and last traded at $2.14, approximately 117,400 shares changed hands during trading. A decline of 79% from the average daily volume of 549,562 shares. The stock had previously closed at $2.00.

Several equities analysts have issued reports on the company. Zacks Investment Research upgraded Rewalk Robotics from a “sell” rating to a “hold” rating in a research note on Tuesday, October 15th. ValuEngine downgraded shares of Rewalk Robotics from a “buy” rating to a “hold” rating in a report on Thursday, November 14th. Finally, HC Wainwright reissued a “buy” rating and set a $9.00 price target on shares of Rewalk Robotics in a research report on Friday, November 15th.

The firm’s 50 day moving average is $2.73 and its 200 day moving average is $3.49. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.34 and a current ratio of 2.66. The stock has a market cap of $15.32 million, a P/E ratio of -0.15 and a beta of 1.56.

Rewalk Robotics (NASDAQ:RWLK) last announced its earnings results on Wednesday, November 13th. The medical device company reported ($0.46) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.45) by ($0.01). Rewalk Robotics had a negative net margin of 322.41% and a negative return on equity of 192.14%. The firm had revenue of $1.23 million during the quarter, compared to analyst estimates of $3.27 million. As a group, analysts expect that Rewalk Robotics Ltd will post -2.62 EPS for the current fiscal year.

A hedge fund recently bought a new stake in Rewalk Robotics stock. Gabelli Funds LLC acquired a new position in Rewalk Robotics Ltd (NASDAQ:RWLK) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 27,064 shares of the medical device company’s stock, valued at approximately $118,000. Gabelli Funds LLC owned approximately 0.60% of Rewalk Robotics at the end of the most recent reporting period. Institutional investors and hedge funds own 7.60% of the company’s stock.

About Rewalk Robotics (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Recommended Story: What is meant by a buy rating?

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with's FREE daily email newsletter.